A viral codon usage strategy enhances antigen production and protection in SFTSV mRNA vaccination. [PDF]
Cha I +13 more
europepmc +1 more source
Virus envelope glycoprotein targeting bispecific T cell engager protects mice from lethal severe fever with thrombocytopenia virus infection. [PDF]
Peng X +21 more
europepmc +1 more source
A Focus on the Mechanisms of Alteration in Host Lymphocyte Level Following Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV) Infection. [PDF]
Chen Y +10 more
europepmc +1 more source
Co-Circulation of Tick-Borne <i>Bandaviruses</i> and <i>Orthonairoviruses</i> Across Humans, Livestock, and Rats in Pakistan: Serologic Evidence and Public Health Implications. [PDF]
Ammar M +16 more
europepmc +1 more source
Epidemic potential of SFTSV: increasing evidence for non-vector-borne transmission
Wen Zheng +3 more
openaire +1 more source
Multi-Epitope mRNA Vaccine Targeting <i>Dabie Bandavirus</i> Glycoprotein: An Immunoinformatics-Based Study. [PDF]
Ahmed SF +6 more
europepmc +1 more source
Novel SFTSV Phylogeny Reveals New Reassortment Events and Migration Routes [PDF]
Severe fever with thrombocytopenia syndrome virus (SFTSV), the causative agent of a febrile human disease, was first identified from central and eastern provinces in China, and later in Japan and South Korea. Hubei Province is one of the major SFTS epidemic areas in the central part of China.
Boyun Liang, Shuang Tang, Hualin Wang
exaly +3 more sources

